February 24, 2022
By David Jensen, Staff Writer, MasterControl
Many medical device manufacturing businesses are busily exploring ways to reduce the soaring costs of health care. Medical device remanufacturer Northeast Scientific is contributing to the effort by repurposing single-use devices (SUDs) to make them fit and safe to reuse.
February 22, 2022
By David Butcher, Staff Writer, MasterControl
Manufacturers sometimes make the mistake of viewing automation or digitization in manufacturing as a replacement for workers rather than as a means of supporting and enhancing workers. In failing to invest in digital manufacturing solutions as tools to optimize people on the shop floor, manufacturers miss out on the real benefits of digital transformation, including time efficiencies, new business intelligence, and greater productivity.
February 15, 2022
By Sarah Beale, Staff Writer, MasterControl
To improve quality, life sciences companies need to bring that data together, use automated analytics tools, and use artificial intelligence (AI) to improve performance. There are three main ways we’re preparing to help you do that.
These seven concepts are critical to understanding the U.S. Food and Drug Administration’s guidance “Quality Systems Approach to the Pharmaceutical Current Good Manufacturing Practice Regulations.”
February 8, 2022
By Dale Thompson, Staff Writer, MasterControl
In addition to focusing on more resilient supply chains, the pharma industry needs to prioritize ways to reduce human error in manufacturing. Human errors cost time and money, but they are often preventable.
February 3, 2022
By Sarah Beale, Staff Writer, MasterControl
The United Kingdom’s (UK) Medicines and Healthcare products Regulatory Agency (MHRA) recently issued new guidance pertaining to regulated medical devices in the UK. Here’s how to prepare.
January 27, 2022
By Dale Thompson, Staff Writer, MasterControl
Pharmaceutical companies need to partner with contract manufacturers capable of maintaining impeccable product quality. Follow these three tips to find a CMO in the pharma industry that can meet and exceed expectations.
January 25, 2022
By Sarah Beale, Staff Writer, MasterControl
It pays to have backup plans, and the supply chain is no different. Constantly fluctuating COVID-19 protocols and transportation issues continue to plague the medical device industry, but there are steps that can be taken to deal with these problems.
January 20, 2022
By Regina Fullin, Vice President of RA/QA Consulting, Compliance Team
No pharma company wants to fail an inspection, and yet it’s common for these five mistakes to interfere with compliance efforts. Industry expert Nicole Cannon offers tips on how to avoid them along with insight into how digitization can be part of the solution. Follow her advice to get safe, effective products to market quickly.
January 18, 2022
By David Butcher, Staff Writer, MasterControl
While visibility, agility, and responsiveness have been priorities in managing supply chains for decades, the disruption and volatility around the COVID-19 pandemic amplified their critical role. In doing so, it brought to light the need to digitize and integrate supply chain systems to ensure all relevant data and insights can be connected for optimal resiliency.
To protect themselves in the face of supply chain volatility, medical device manufacturers should reassess their supply chain capabilities with an eye toward proactive, tech-enabled solutions.
January 13, 2022
By Dale Thompson, Staff Writer, MasterControl
The FDA has signaled that data integrity is increasingly central to the drug approval process. Pharma organizations need to take the cue and adopt a quality management system that improves their ability to record and manage data, which will streamline their compliance efforts.
January 11, 2022
By Edwin Chung, District Manager, Director of Engineering Technology & Applications, SPK and Associates
A medical device manufacturer was working across two disparate systems. The result? Mistakes made their way into the manufacturing process, which resulted in lengthy review times, and delayed speed to market. The solution was digitization, and it immediately saved them $42,000 per year.
January 6, 2022
By David Jensen, Staff Writer, MasterControl
Given the high numbers of pharmaceutical recalls and shortages, along with the current supply chain issues, product manufacturers are making modernization a higher priority. This post examines the new pharmaceutical manufacturing trends in modernization.
December 16, 2021
By Sarah Beale, Staff Writer, MasterControl
Artificial intelligence (AI) in health care has enormous potential, but AI-enabled software as a medical device (SaMD) is charting new territory. Last year, regulators indicated some of their priorities for AI in SaMD and what regulations might look like in the future.
December 14, 2021
By James Jardine, GxP Lifeline Editor, MasterControl
FDA and other regulators are increasingly cracking down on pharma companies’ data integrity lapses. Learn the fundamentals of maximizing data usage that will help keep your quality and compliance activities aligned with regulatory expectations.
December 9, 2021
By David Butcher, Staff Writer, MasterControl
As the field of personalized medicine grows and evolves, and regulatory agencies such as the U.S. Food and Drug Administration (FDA) take steps to address regulatory oversight in the field, affected organizations should brace themselves for change and use it to their advantage. Here are three ways that companies in personalized medicine can approach regulatory obstacles as opportunities instead.
December 8, 2021
By Dale Thompson, Staff Writer, MasterControl
With manufacturers digitizing at a rapid rate, understanding the core of the European Union’s (EU) guidelines, Annex 11, and its approximate FDA counterpart, 21 CFR Part 11, is more critical than ever. They are central to understanding the conditions for life sciences manufacturers’ electronic data in the EU and the U.S., and while the guidance is similar in both countries, it’s important to understand the key differences.
December 7, 2021
By David Jensen, Staff Writer, MasterControl
Receiving a warning letter involves action items and additional correspondence with the U.S. Food and Drug Administration (FDA). All of which delays your company in getting product out the door. Learn some of the common reasons life sciences companies receive FDA warning letters, so you can avoid making the same mistakes.
Inadequate quality management and poor data can be costly for a life sciences company or similarly regulated industry. However, a strong corrective action/preventive action (CAPA) program paired with a digital CAPA management tool can help differentiate your company from the competition.
Support for the Internet Explorer browser will end on June 15, 2022 and some site features may be unavailable.
For the best experience, we recommend using a modern web browser such as Google Chrome, Mozilla Firefox or Microsoft Edge.
